FrancophonIA/ELRC3.0 huggingface dataset:
English: Adempas 1.5 mg film-coated tablets Each film-coated tablet contains 1.5 mg riociguat.
Slovenian: Adempas 1,5 mg filmsko obložene tablete Ena filmsko obložena tableta vsebuje 1,5 mg riociguata.
English: Adempas 1 mg film-coated tablets Each film-coated tablet contains 1 mg riociguat.
Slovenian: Adempas 1 mg filmsko obložene tablete Ena filmsko obložena tableta vsebuje 1 mg riociguata.
English: Adempas 2 mg film-coated tablets
Slovenian: Adempas 2 mg filmsko obložene tablete
English: Adempas 2 mg film-coated tablets Each film-coated tablet contains 2 mg riociguat.
Slovenian: Adempas 2 mg filmsko obložene tablete Ena filmsko obložena tableta vsebuje 2 mg riociguata.
English: CYP1A1 catalyses the formation of riociguat's main metabolite in liver and lungs and is known to be inducible by polycyclic aromatic hydrocarbons, which, for example, are present in cigarette smoke.
Slovenian: Znano je, da ga inducirajo policiklični aromatski ogljikovodiki, ki so, na primer, prisotni v cigaretnem dimu.
English: Each 0.5 mg film-coated tablet contains 37.8 mg lactose (as monohydrate).
Slovenian: Ena filmsko obložena tableta po 0,5 mg vsebuje 37,8 mg laktoze (v obliki laktoze monohidrata).
English: Mean change from PVR baseline (dyn·s·cm-5) [SD]
Slovenian: povprečna sprememba od izhodiščne vrednosti PVR (dyn·s·cm-5)
English: Adempas 0.5 mg film-coated tablets
Slovenian: Adempas 0,5 mg filmsko obložene tablete
English: Baseline (dyn·s·cm-5) [SD]
Slovenian: izhodiščna vrednost (dyn·s·cm-5)
English: • certain types of pulmonary arterial hypertension (PAH).
Slovenian: • določene oblike pljučne arterijske hipertenzije (PAH - pulmonary arterial hypertension) Pri PAH se krvne žile v pljučih zožijo zaradi zadebelitve sten teh žil.
English: Respiratory, thoracic and mediastinal disorders
Slovenian: Infekcijske in parazitske bolezni gastroenteritis
English: Adempas 2.5 mg film-coated tablets Each film-coated tablet contains 2.5 mg riociguat.
Slovenian: Adempas 2,5 mg filmsko obložene tablete Ena filmsko obložena tableta vsebuje 2,5 mg riociguata.
English: Gastrointestinal and abdominal pains, Constipation, Abdominal distension
Slovenian: Bolezni prebavil dispepsija, driska, navzea, bruhanje gastritis, gastroezofagealna refluksna bolezen, disfagija, bolečine v prebavilih in trebuhu, zaprtje, abdominalna distenzija
English: Adempas 2.5 mg film-coated tablets
Slovenian: Adempas 2,5 mg filmsko obložene tablete
English: Monitor for signs and symptoms of hypotension on initiation and on treatment.
Slovenian: Pri uvedbi zdravila in v času zdravljenja je treba spremljati znake in simptome hipotenzije.
English: Adempas 1.5 mg film-coated tablets
Slovenian: Adempas 1,5 mg filmsko obložene tablete
English: * fatal pulmonary haemorrhage was reported in uncontrolled long term extension studies
Slovenian: * v dolgotrajnem podaljšanju študije (brez primerjalne skupine) so poročali o krvavitvi v pljučih s smrtnim izidom
English: You should not breast-feed while taking this medicine.
Slovenian: Ko jemljete to zdravilo, ne smete dojiti.
English: ATC code: C02KX05
Slovenian: Farmakoterapevtska skupina: antihipertenzivi (antihipertenzivi za zdravljenje pljučne arterijske hipertenzije), oznaka ATC: C02KX05
English: Adempas 2 mg film-coated tablets EU/1/13/907/010
Slovenian: Adempas 2 mg filmsko obložene tablete EU/1/13/907/010
English: Adempas 0.5 mg film-coated tablets Adempas 1 mg film-coated tablets Adempas 1.5 mg film-coated tablets Adempas 2 mg film-coated tablets Adempas 2.5 mg film-coated tablets riociguat
Slovenian: Adempas 0,5 mg filmsko obložene tablete Adempas 1 mg filmsko obložene tablete Adempas 1,5 mg filmsko obložene tablete Adempas 2 mg filmsko obložene tablete Adempas 2,5 mg filmsko obložene tablete riociguat
English: In this case, your doctor will prescribe you Adempas at the highest dose you are comfortable on. For some patients lower doses three times a day might be sufficient, the optimal dose will be selected by your doctor.
Slovenian: V tem primeru vam bo zdravnik predpisal največji odmerek zdravila Adempas, ki je za vas primeren.
English: Adempas 0.5 mg film-coated tablets Adempas 1 mg film-coated tablets Adempas 1.5 mg film-coated tablets Adempas 2 mg film-coated tablets Adempas 2.5 mg film-coated tablets
Slovenian: Adempas 0,5 mg filmsko obložene tablete Adempas 1 mg filmsko obložene tablete Adempas 1,5 mg filmsko obložene tablete Adempas 2 mg filmsko obložene tablete Adempas 2,5 mg filmsko obložene tablete
English: Each 1.5 mg film-coated tablet contains 36.8 mg lactose (as monohydrate).
Slovenian: Adempas 1,5 mg filmsko obložene tablete Ena filmsko obložena tableta po 1,5 mg vsebuje 36,8 mg laktoze (v obliki laktoze monohidrata).
English: Adempas is indicated for the treatment of adult patients with WHO Functional Class (FC) II to III with
Slovenian: Zdravilo Adempas je indicirano za zdravljenje odraslih bolnikov II.
English: Adempas 1 mg film-coated tablets EU/1/13/907/004
Slovenian: Adempas 1 mg filmsko obložene tablete EU/1/13/907/004
English: your kidneys do not work properly (creatinine clearance < 30 ml/min) or if you are on dialysis as the use of this medicine is not recommended.
Slovenian: - če vaše ledvice ne delujejo pravilno (očistek kreatinina < 30 ml/min) ali če ste na dializi, ker se uporaba tega zdravila ne priporoča, - če imate zmerne težave z jetri (jetrno okvaro, Child Pugh B), - če ste med zdravljenjem s tem zdravilom začeli ali prenehali kaditi, ker to lahko vliva na vrednosti riociguata v vaši krvi.
English: hydroxypropylcellulose hypromellose 3 cP propylene glycol (E 1520) titanium dioxide (E 171) iron oxide yellow (E 172)
Slovenian: hidroksipropilceluloza hipromeloza 3 cP propilenglikol (E 1520) titanov dioksid (E 171) rumeni železov oksid (E 172) (samo v tabletah z jakostjo 1 mg, 1,5 mg, 2 mg in 2,5 mg) rdeči železov oksid (E 172) (samo v tabletah z jakostjo 2 mg in 2,5 mg)
English: if you are taking nitrates or nitric oxide donors (such as amyl nitrite) in any form, medicines often used to treat high blood pressure, chest pain or heart disease.
Slovenian: - če jemljete nitrate ali donorje dušikovega oksida (kot je amilnitrit) v kakršni koli obliki,
English: Adempas 2.5 mg film-coated tablets EU/1/13/907/013
Slovenian: Adempas 2,5 mg filmsko obložene tablete EU/1/13/907/013
English: Each 2 mg film-coated tablet contains 36.3 mg lactose (as monohydrate).
Slovenian: Adempas 2 mg filmsko obložene tablete Ena filmsko obložena tableta po 2 mg vsebuje 36,3 mg laktoze (v obliki laktoze monohidrata).
English: Adempas 2.5 mg - pack of 294 film-coated tablets - EU/1/13/907/020
Slovenian: Adempas 2,5 mg - pakiranje z 294 filmsko obloženimi tabletami - EU/1/13/907/020
English: Patients older than 65 years are at increased risk of hypotension.
Slovenian: Pri bolnikih, starejših od 65 let, je tveganje za hipotenzijo večje, zato je pri uporabi riociguata pri teh bolnikih potrebna previdnost.
English: Each 1 mg film-coated tablet contains 37.2 mg lactose (as monohydrate).
Slovenian: Adempas 1 mg filmsko obložene tablete Ena filmsko obložena tableta po 1 mg vsebuje 37,2 mg laktoze (v obliki laktoze monohidrata).
English: Placebo-adjusted difference (ng/L) 95% CI, [p-value]
Slovenian: izhodiščna vrednost (ng/l) [SD] povprečna sprememba od izhodiščne vrednosti (ng/l) [SD] glede na placebo prilagojena razlika (ng/l)
English: The class of tyrosine kinase inhibitors was identified as potent inhibitors of CYP1A1, with erlotinib and gefitinib exhibiting the highest inhibitory potency in vitro.
Slovenian: Zaviralci tirozin-kinaze so bili opredeljeni kot razred močnih zaviralcev CYP1A1.
English: Each 2.5 mg film-coated tablet contains 35.8 mg lactose (as monohydrate).
Slovenian: Adempas 2,5 mg filmsko obložene tablete Ena filmsko obložena tableta po 2,5 mg vsebuje 35,8 mg laktoze (v obliki laktoze monohidrata).
English: Adempas 2 mg - pack of 90 film-coated tablets - EU/1/13/907/012
Slovenian: Adempas 2 mg - pakiranje z 90 filmsko obloženimi tabletami - EU/1/13/907/012
English: Adempas 1 mg - pack of 90 film-coated tablets - EU/1/13/907/006
Slovenian: Adempas 1 mg - pakiranje z 90 filmsko obloženimi tabletami - EU/1/13/907/006
English: • 0.5 mg tablet: white, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side and 0.5 and an “R” on the other side.
Slovenian: • tableta po 0,5 mg: bele, okrogle, bikonveksne tablete velikosti 6 mm, na eni strani označene z oznako Bayer in na drugi strani z oznakama "0.5" in "R"
English: Adempas 1.5 mg film-coated tablets EU/1/13/907/007
Slovenian: Adempas 1,5 mg filmsko obložene tablete EU/1/13/907/007
English: Adempas 0.5 mg film-coated tablets EU/1/13/907/001
Slovenian: Adempas 0,5 mg filmsko obložene tablete EU/1/13/907/001
English: Adempas 1 mg - pack of 294 film-coated tablets - EU/1/13/907/017
Slovenian: Adempas 1 mg - pakiranje z 294 filmsko obloženimi tabletami - EU/1/13/907/017
English: Adempas 2 mg - pack of 84 film-coated tablets - EU/1/13/907/011
Slovenian: Adempas 2 mg - pakiranje s 84 filmsko obloženimi tabletami - EU/1/13/907/011
English: Merck Sharp & Dohme Cyprus Limited Τηλ: 800 00 673 (+357 22866700) cyprus_info@merck.com
Slovenian: Merck Sharp & Dohme Cyprus Limited Τηλ: 800 00 673
English: Placebo-adjusted difference (m) 95% CI, [p-value]
Slovenian: 95-odstotni IZ, [vrednost p]
English: Adempas 2.5 mg - pack of 84 film-coated tablets - EU/1/13/907/014
Slovenian: Adempas 2,5 mg - pakiranje s 84 filmsko obloženimi tabletami - EU/1/13/907/014
English: Adempas 2.5 mg - pack of 90 film-coated tablets - EU/1/13/907/015
Slovenian: Adempas 2,5 mg - pakiranje z 90 filmsko obloženimi tabletami - EU/1/13/907/015
English: Adempas 2.5 mg - pack of 42 film-coated tablets - EU/1/13/907/013
Slovenian: Adempas 2,5 mg - pakiranje z 42 filmsko obloženimi tabletami - EU/1/13/907/013
English: • 2.5 mg tablet: red-orange, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side and 2.5 and an “R” on the other side.
Slovenian: • tableta po 2,5 mg: rdeče-oranžne, okrogle, bikonveksne tablete velikosti 6 mm, na eni strani označene z oznako Bayer in na drugi strani z oznakama "2.5" in "R"
English: Adempas 1.5 mg - pack of 90 film-coated tablets - EU/1/13/907/009
Slovenian: Adempas 1,5 mg - pakiranje z 90 filmsko obloženimi tabletami - EU/1/13/907/009
English: Adempas 1.5 mg - pack of 42 film-coated tablets - EU/1/13/907/007
Slovenian: Adempas 1,5 mg - pakiranje z 42 filmsko obloženimi tabletami - EU/1/13/907/007
English: Adempas 1 mg - pack of 84 film-coated tablets - EU/1/13/907/005
Slovenian: Adempas 1 mg - pakiranje s 84 filmsko obloženimi tabletami - EU/1/13/907/005
English: Adempas 0.5 mg - pack of 90 film-coated tablets - EU/1/13/907/003
Slovenian: Adempas 0,5 mg - pakiranje z 90 filmsko obloženimi tabletami - EU/1/13/907/003
English: Adempas 1.5 mg - pack of 84 film-coated tablets - EU/1/13/907/008
Slovenian: Adempas 1,5 mg - pakiranje s 84 filmsko obloženimi tabletami - EU/1/13/907/008
English: Adempas 0.5 mg - pack of 84 film-coated tablets - EU/1/13/907/002
Slovenian: Adempas 0,5 mg - pakiranje s 84 filmsko obloženimi tabletami - EU/1/13/907/002
English: Adempas 2 mg - pack of 294 film-coated tablets - EU/1/13/907/019
Slovenian: Adempas 2 mg - pakiranje z 294 filmsko obloženimi tabletami - EU/1/13/907/019
English: Adempas 0.5 mg - pack of 42 film-coated tablets - EU/1/13/907/001
Slovenian: Adempas 0,5 mg - pakiranje z 42 filmsko obloženimi tabletami - EU/1/13/907/001
English: • 1.5 mg tablet: yellow-orange, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side and 1.5 and an “R” on the other side.
Slovenian: • tableta po 1,5 mg: rumeno-oranžne, okrogle, bikonveksne tablete velikosti 6 mm, na eni strani označene z oznako Bayer in na drugi strani z oznakama "1.5" in "R"
English: Riociguat IDT (n=108)
Slovenian: funkcijskega razreda riociguat IDT (n = 108)
English: Mean change from baseline (m) [SD]
Slovenian: izhodiščna vrednost (m) [SD] povprečna sprememba od izhodiščne vrednosti (m) [SD] glede na placebo prilagojena razlika (m)
English: België / Belgique / Belgien MSD Belgium BVBA/SPRL Tél/Tel: +32(0)27766211 dpoc_belux@merck.com
Slovenian: Tel/Tél: +32(0)27766211 dpoc_belux@merck.com
English: Blood and lymphatic system disorders
Slovenian: Bolezni krvi in limfatičnega sistema anemija (vključno z laboratorijskimi parametri anemije)
English: • 2 mg tablet: pale orange, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side and 2 and an “R” on the other side.
Slovenian: • tablete po 2 mg: svetloranžne, okrogle, bikonveksne tablete velikosti 6 mm, na eni strani označene z oznako Bayer in na drugi strani z oznakama 2 in "R"
English: Mean change from baseline (dyn·s·cm-5) [SD]
Slovenian: povprečna sprememba od izhodiščne vrednosti (dyn·s·cm-5)
English: • 1 mg tablet: pale yellow, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side and 1 and an “R” on the other side.
Slovenian: • tablete po 1 mg: svetlorumene, okrogle, bikonveksne tablete velikosti 6 mm, na eni strani označene z oznako Bayer in na drugi strani z oznakama 1 in "R"
English: Bottle (HDPE)
Slovenian: Uporaba v panju Plastenka (HDPE)
English: Sachet (PET/Alu/L DPE)
Slovenian: Uporaba v panju Vrečica (PET/Alu/LDPE)
English: 12 sachets Honey: Zero days
Slovenian: 12 vrečic Med: nič dni
English: 1 bottle Honey: Zero days
Slovenian: 1 plastenka Med: nič dni
English: EU/2/16/203/002 VarroMed 660 mg / 75 mg
Slovenian: 660 mg/75 mg
English: EU/2/16/203/001 VarroMed 44 mg/ml / 5 mg/ml
Slovenian: 44 mg/ml/ 5 mg/ml
English: • are a young adult.
Slovenian: • ste mlajša odrasla oseba.
English: You may be more likely to think like this if you:
Slovenian: Pojav takšnih misli je verjetnejši, če:
English: • depression;
Slovenian: • depresije;
English: 7 Not statistically significantly different from placebo.
Slovenian: 7 Ni statistično različno od placeba.
English: 3 See section 4.4.
Slovenian: 3 Glejte poglavje 4.4.
English: • tinnitus (hearing sound in the ear when there is no external sound);
Slovenian: • tinitus (zvonjenje v ušesih, kljub temu da ni zunanjega zvoka)
English: Frequency estimate: Very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000).
Slovenian: Ocene pogostnosti: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000).
English: • have previously had thoughts about killing or harming yourself;
Slovenian: • ste že kdaj razmišljali o samomoru ali samopoškodovanju;
English: • are currently being treated with another medicine which may cause liver damage;
Slovenian: • se trenutno zdravite z drugimi zdravili, ki lahko povzročijo poškodbo jeter;
English: Do not drive or use any tools or machines until you know how Duloxetine Zentiva affects you.
Slovenian: Ne vozite in ne upravljajte z orodji ali stroji, dokler ne veste, kako zdravilo Duloksetin Zentiva vpliva na vas.
English: • are at risk of low sodium levels (for example if you are taking diuretics, especially if you are elderly);
Slovenian: • imate tveganje za nizek nivo natrija (če na primer jemljete diuretike, sploh če ste starejši);
English: • painful urination, frequent urination;
Slovenian: • boleče uriniranje, pogosto uriniranje
English: • are allergic to duloxetine or any of the other ingredients of this medicine (listed in section 6);
Slovenian: • ste alergični na duloksetin ali katero koli sestavino tega zdravila (navedeno v poglavju 6);
English: • are taking fluvoxamine which is usually used to treat depression, ciprofloxacin or enoxacin which are used to treat some infections.
Slovenian: • jemljete fluvoksamin, ki se običajno uporablja za zdravljenje depresije, ciprofloksacin ali enoksacin, ki se uporablja za zdravljenje nekaterih okužb;
English: Other psychiatric conditions for which duloxetine is prescribed can also be associated with an increased risk of suicide-related events.
Slovenian: Druga psihiatrična stanja, za katera predpisujemo duloksetin so tudi lahko povezana z večjim tveganjem za pojav dogodkov povezanih s samomorom.
English: A conclusion on the overall benefit/risk in this age group has not been established (see also sections 4.2 and 4.8).
Slovenian: Zaključek glede splošnih koristi/tveganj pri tej starostni skupini ni bil podan (glejte tudi poglavji 4.2 in 4.8).
English: These medicines increase the risk of side effects; if you get any unusual symptom taking any of these medicines together with Duloxetine Zentiva, you should see your doctor.
Slovenian: Ta zdravila povečajo tveganje za neželene učinke; če se pojavi kakršenkoli neobičajen simptom ob jemanju katerega od teh zdravil skupaj z zdravilom Duloksetin Zentiva, obiščite svojega zdravnika.
English: • generalised anxiety disorder (chronic feeling of anxiety or nervousness);
Slovenian: • generalizirane anksiozne motnje (kroničen občutek tesnobe ali nervoznosti);
English: Pharmacokinetic differences have been identified between younger and elderly females (≥ 65 years) (AUC increases by about 25% and half-life is about 25% longer in the elderly), although the magnitude of these changes is not sufficient to justify adjustments to the dose.
Slovenian: Ugotavljali so farmakokinetične razlike med mlajšimi in starejšimi ženskami (≥ 65 let) (pri starejših se AUC poviša za približno 25 %, razpolovni čas pa je daljši za približno 25 %), vendar obseg teh sprememb ni tolikšen, da bi upravičil prilagajanje odmerka.
English: The risk of using duloxetine in combination with other CNS-active medicinal products has not been systematically evaluated, except in the cases described in this section.
Slovenian: Tveganja uporabe duloksetina v kombinaciji z drugimi zdravili, ki delujejo na CŽS, niso sistematično vrednotili, razen v primerih, opisanih v tem poglavju.
English: Duloxetine should be used in pregnancy only if the potential benefit justifies the potential risk to the foetus.
Slovenian: Duloksetin naj se v nosečnosti uporablja le, če možna korist upravičuje možno tveganje za plod.
English: Antacids and H2 antagonists
Slovenian: Antacidi in antagonisti H2
English: There may be loss of feeling in the affected area, or sensations such as touch, heat, cold or pressure may cause pain).
Slovenian: V prizadetem področju lahko pride do izgube zaznavanja, ali občutki, denimo dotik, toplota, mraz ali pritisk povzročijo bolečino).
English: Some patients who stop taking Duloxetine Zentiva suddenly have had symptoms such as:
Slovenian: Nekateri bolniki, ki so nenadoma prenehali jemati zdravilo Duloksetin Zentiva, so imeli simptome, kot so:
English: • menopausal symptoms, abnormal production of breast milk in men or women.
Slovenian: • menopavzalni simptomi, nenormalno nastajanje mleka v dojkah pri moških in ženskah
English: • serious allergic reaction which causes difficulty in breathing or dizziness with swollen tongue or lips, allergic reactions;
Slovenian: • resne alergične reakcije, ki povzročajo težave pri dihanju ali omotico z oteklim jezikom ali ustnicami, alergične reakcije
English: If your doctor has prescribed Duloxetine Zentiva for a patient under 18 and you want to discuss this, please go back to your doctor.
Slovenian: Če je vaš zdravnik predpisal zdravilo Duloksetin Zentiva bolniku, mlajšemu od 18 let, in se želite o tem pogovoriti, se, prosimo, obrnite na svojega zdravnika.
English: Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Slovenian: Bolniki z redko dedno intoleranco za fruktozo, malabsorpcijo glukoze/galaktoze ali pomanjkanjem saharoza-izomaltaze ne smejo jemati tega zdravila.
English: Oral contraceptives and other steroidal agents Results of in vitro studies demonstrate that duloxetine does not induce the catalytic activity of CYP3A.
Slovenian: Peroralni kontraceptivi in druge steroidne učinkovine Rezultati študij in vitro kažejo, da duloksetin ne inducira katalitske aktivnosti CYP3A.
English: Very rare side effects (may affect up to 1 in 10,000 people): • inflammation of the blood vessels in the skin (cutaneous vasculitis).
Slovenian: Zelo redki neželeni učinki (se lahko pojavijo pri največ 1 od 10.000 bolnikov): • vnetje krvnih žil v koži (kožni vaskulitis)
English: Duloxetine was studied in a clinical programme involving 3,158 patients (1,285 patient-years of exposure) meeting DSM-IV criteria for major depression.
Slovenian: Duloksetin so preučevali v kliničnem programu, v katerem je sodelovalo 3.158 bolnikov (1.285 bolniških let izpostavljenosti), ki so izpolnjevali merila DSM-IV za veliko depresivno motnjo.
English: • have eye problems, such as certain kinds of glaucoma (increased pressure in the eye);
Slovenian: • imate težave z očmi, denimo določene vrste glavkoma (zvišan tlak v očesu);
English: Only a small proportion of patients included in pivotal clinical trials had severe depression (baseline HAM-D > 25).
Slovenian: Le majhen delež bolnikov, sodelujočih v presečnih kliničnih preskušanjih, je imel hudo depresijo (izhodiščno število točk po HAM-D > 25).
English: The dose may be adjusted up to 120 mg a day based on your response to Duloxetine Zentiva.
Slovenian: Odmerek bo morda prilagojen do 120 mg na dan, glede na vaš odziv na zdravilo Duloksetin Zentiva.
English: 2 Cases of orthostatic hypotension and syncope have been reported especially at the initiation of treatment.
Slovenian: 2 O primerih ortostatske hipotenzije in sinkope so poročali zlasti ob začetku zdravljenja.
English: • have had mania;
Slovenian: • ste imeli manijo;
English: • falls (mostly in elderly people), fatigue;
Slovenian: • padci (predvsem pri starejših), utrujenost
English: • have a history of bleeding disorders (tendency to develop bruises), especially if you are pregnant (see ‘Pregnancy and breast-feeding‘);
Slovenian: • ste v preteklosti imeli motnje strjevanja krvi (nagnjenost k razvoju podplutb), sploh če ste noseči (glejte ‘Nosečnost in dojenje‘);
English: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Slovenian: Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte se s svojim zdravnikom ali s farmacevtom, preden vzamete to zdravilo.
English: 4 Cases of aggression and anger have been reported particularly early in treatment or after treatment discontinuation.
Slovenian: 4 O primerih agresije in jeze so poročali zlasti ob začetku zdravljenja in po prekinitvi zdravljenja.
English: • Oral anticoagulants or antiplatelet agents: Medicines which thin the blood or prevent the blood from clotting.
Slovenian: • Peroralni antikoagulanti ali antitrombotiki: zdravila za redčenje krvi ali preprečevanje strjevanja krvi.
English: • Stevens-Johnson syndrome (serious illness with blistering of the skin, mouth, eyes and genitals), serious allergic reaction which causes swelling of the face or throat (angioedema);
Slovenian: • Stevens-Johnsonov sindrom (resna bolezen z mehurji na koži, ustih, očeh in genitalijah), resne alergične reakcije, ki povzročijo otekanje obraza ali grla (angioedem)
English: You should use Duloxetine Zentiva only after discussing the potential benefits and any potential risks to your unborn child with your doctor.
Slovenian: Zdravilo Duloksetin Zentiva lahko uporabljate le po tem, ko ste se o možnih koristih in morebitnih možnih tveganjih za vašega nerojenega otroka pogovorili s svojim zdravnikom.
English: • problems getting an erection, changes in ejaculation;
Slovenian: • težave z erekcijo, spremembe v ejakulaciji
English: However, as with any medicine, caution should be exercised when treating the elderly, especially with duloxetine 120 mg per day for major depressive disorder or generalised anxiety disorder, for which data are limited (see sections 4.4 and 5.2).
Slovenian: Vendar pa je, kot pri vseh zdravilih, pri zdravljenju starejših potrebna previdnost, posebno z duloksetinom 120 mg na dan za zdravljenje velike depresivne motnje ali generalizirane anksiozne motnje, za kar je na voljo malo podatkov (glejte poglavji 4.4 in 5.2).
English: • headache, feeling sleepy;
Slovenian: • glavobol, občutek zaspanosti